Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Current there's 5X Sell Volume to Buy Volume...so the PPS is going to definitely trend downward.
I would set a Buy Order at 0.01.
Cheers!
So what you're suggesting is a world class BioTechnology Company (BioClonetics) presently worth $132M headed by a world class scientific physician leader in the same league as Dr. Facui, who developed and holds the ONLY Patent in world history for Clone-3 Antibody that took decades to develop and has the PROVEN ability to neutralize 95% of all known strains of HIV, with application for the same for other infections diseases such as rabies, influenza, tetanus, diphtheria, and Covid-19, would merge his company with a Fake "pink sheet" "company"??? Is that what you're suggesting??? I suggest you move over to Nasdaq or NYSE.
0.0060 did you say?? GOOD! I'll SNAP UP ANOTHER MILLION SHARES!!!
Thanks!
Nice Stock Price! 0.000001!
a sure winner! LOL!
AMEN PRAISE JESUS!
Human Omentum - Cellular Basis For Tissue Re-generation
Apparently CBBT is in the process of harnessing the Human Omentum's known capacity for cellular regeneration, an already PROVEN FACT!
What this untapped area of Applied Biotechnology represents qualifies as "Disruptive Technology."
Human Omentum has been repeatedly shown to have the capacity to cause cellular regeneration & repair of various organs in the body including NEURONS!!! I posted several links on this yesterday 10/30/20 of several studies verifying the ability of human omentum to increase cerebral blood flow in brain tissue which in turn favors sustained neuron viability, and theoretically helps prevent the on-set or progress of Alzheimer's symptoms.
One study even showed that if arterial supply to a region of the brain is "tied off" by a surgeon, and then Human Omentum is placed over the area of the brain that the tied off artery supplied, the brain cells in that region of the brain continue to thrive as if the artery supply was never interrupted.
This finding is like something out of a science fiction movie, totally unheard of, totally unexplained, AND it likely represents one of the greatest scientific-medical discovery of modern medicine which CBBT has tapped into with the development of a viable and effective treatment for Alzheimer's.
Know this, Alzheimer's is all about brain cell (neurons) atrophy and death related to decreased blood flow to brain cell tissues with aging. Other mechanisms are involved but this is the primary cause. Nutrients also play a big role in neuron survival and thriving which human omentum highly supports because it's one of the richest nutrient sources in the human body.
Therefore with it's combined effect of causing increased blood flow brain cell tissue in tandem with delivery of high potency nutrients, these forces operating together have the capacity to preserve brain cell function in aging individuals.
This is what CBBT is up to in their Patent development for treating Alzheimer's and as a doctor I believe they are definitely on the right track.
Here's a very brief but major eye-opener video on this topic:
AMEN!
For those of you who are interested, the following is a research article of the fundamental Bio-Technology that CBBT is working on to bring to global commercialization in the treatment of Alzheimer's Disease. So far, in modern medicine, there has been NO effective treatment of any kind to date for this terrible disease that effects more than 44 MILLION people worldwide at enormous expense and suffering; also take a look at this:
Official U.S. death certificates recorded 122,019 deaths from Alzheimer's in 2018, the latest year for which data is available and therefore is significantly higher in 2020 and beyond, thereby making Alzheimer's the sixth (6th) leading cause of death in the United States and the fifth (5th) leading cause of death among Americans age 65 and older.
----
Annals of New York Academy of Science
Nov 2002
Clinical Case Study
Title: Treatment of Alzheimer's Disease by Transposition of the Omentum
Harry S Goldsmith, M.D.
Abstract
Foreword: Transposition of the Omentum refers to surgically extracting Omentum from the abdomen and laying it over top of effected brain tissue where Cerebral Blood Flow is known to be diminished based on MRI-Radiological Tomography. Omentum refers to a large apron-like fold of highly vascularized visceral peritoneum containing a network of blood vessels rich in nutrients that hangs down from the stomach.
There is increasing evidence that cerebral hypo-perfusion (low blood flow) plays a key role in the development of Alzheimer's disease (AD).
As everyone ages, cerebral blood flow (CBF) decreases in direct proportion to the normal aging process. Coupled with this expected drop in Cerebral Blood Flow with aging, are a host of other factors that impact this process such as hypertension, stress, smoking, diabetes, cholesterol buildup, etc., all of which are associated with further decrease blood flow to the brain.
Maintaining a critical level of CBF is essential if adequate amounts of oxygen and glucose are to be presented to brain neurons to sustain their cellular energy production of ATP. ATP is the body's primary source of cellular metabolism and energy production for normal metabolic function and cellular survival in all tissues and organs of the body.
If Cerebral Blood drops below a critical level, insufficient ATP will be produced and, if this situation is not corrected, neurons will deteriorate and eventually die. This describes the primary aging process, neurological decline, and the factors in play that lead to the onset of Alzheimer's Disease (AD).
When a critical mass of neurons die in areas of the brain involved with cognition and memory, (AD) will result.
Omentum transposition to the brain is a surgical procedure by which a large volume of blood and other biological agents can be delivered to the brain over an indefinite period of time.
The Omentum has been proven to support to deteriorating neurons in brain tissue, and furthermore its physical presence directly laid upon the brain itself has shown to produce significant reversal of Alzheimer's Symptoms.
Additionally, Omentum transposition to the brain can markedly reduce senile plaque accumulation.
Omental transposition therefore may play an important role in the future treatment of Alzheimer's Disease, especially in early and moderate cases.
I believe this research article speaks volumes for itself AND it has been CONFIRMED by MANY others over the past several years.
CBBT is DEFINITELY on the right track!
As far as I know, CBBT is the ONLY Biotech out there developing an effective treatment for this disease in the history of modern medicine.
Cheers!
AMEN!!
Keep watching...won't be long now!!!
I know one thing for certain, due to my professional background as a research physician in Clinical Research and conducting Patient based clinical trials, I'm 100% certain that CBBT is definitely on the right track with their "Omentum" Bio-Technology in the treatment of Alzheimer's.
It just thrilling to discover what human Omentum does to neurovascularization even in the face of ligated arteries that have been surgically tied off to observe the effects of Omentum directly lay over neuro tissue in Alzheimer's patients, but yet the neuro-tissues continue to thrive! This is completely and totally unheard of, it is a profound discovery. Omentum has extraordinary vascularization and is thought to be key to human embryo gestation including neurological tissue and vascular development.
Essentially, this is qualifies as "disruptive technology" hands down!
Not only this, this type of research dates back many decades and it is now near certain that it may be the ONLY promising treatment for Alzheimer's for reason NOTHING ELSE WORKS!!! All drug therapies on the market do next to nothing to prevent or treat this terrible disease of aging.
IMO Omentum Treatment of Alzheimer's is the future..starting now with CBBT. The people behind the technology of this company are definitely on the right track, and the links to the articles I provided below definitely bare the reality of this out in vivid description.
Each of the below articles deserves a thorough READ if anyone is interested in what CBBT has, the track they are on, and what we can anticipate from their efforts. I just can't wait until they complete their own clinical trials throughout Europe and other countries.
Here are the links to study in detail. It's A LOT of reading, but definitely worth it for anyone seriously invested in the stock as a Long.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523480/
https://www.mpo-mag.com/contents/view_breaking-news/2013-08-28/a-device-solution-for-alzheimers/
https://www.tandfonline.com/doi/abs/10.1080/01616412.1996.11740387
https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1749-6632.1997.tb48483.x (eye opening article)
https://clinicaltrials.gov/ct2/show/NCT02349191
What MANY people here are forgetting is that once upon a time not very long ago, APPLE & AMAZON were PENNY STOCKS!!! LOL!
Agreed! Just about to post the exact same thing!
Cheers!
By December 31st, we may be looking at 0.10 to 0.50
By June 2021, $1.00 to $1.50
This time next year, $2.50, possibly higher...
Clinical trials underway, $3.50 to $8.00
1st year Product commercialization $10-$15 transitioning onto NASDAQ with steady earnings....
Year-2 commercialization $25-$85 trading many times earnings
IMO only...
Fundamentally, CBBT post acquisition immediately qualifies as a NASDAQ Biotech trading at many times earnings like ALL of them do!
Well said! 100% CORRECT!!
This company can only compare with early stage Biotechs trading on NASDAQ prior to earnings, or even those with negative earnings, due to the large multiples they are known to trade at.
CBBT will soon be on NASDAQ once they go full blown production post acquisition.
100% CORRECT!!!
CBBT is without question destine to become on on the BIGGEST BioTech Companies in existence relative to the need they meet for people suffering from an extremely debilitating disease like Alzheimer's. Even if they can't cure it, they have the technology & patent to effectively treat it like nothing else in existence.
So the way I view this Company is they have "disruptive" technology they are in the process of bringing to the Global Market.
In the not so distant future, we're going to see CBBT trading on one of the major Exchanges trading at 40-80X earning like many of the big Biotech's which will likely result in a PPS North of $50/share if not A LOT higher.
Within a year of product development and sales beginning to fall to their bottom line, I expect the PPS to be above $10 per share.
In anticipation of this, with Institutional Investors beginning to take notice this Company, I can see the PPS trading in the $3-5 range within 6-12 months from now!
Only my opinion, but I strongly believe it's spot on!
Be well and prosper....Long & Strong!
That would be GREAT!! Then I can snap up another 2-3 Million Shares!!!!
Stock Invest says > 151% gain in the PPS over the next thee (3) months!
Personally, I believe it will be A LOT HIGHER, i.e. $1-2.50 minimum by Jan-Feb 2021.
Any perspectives on this?
https://stockinvest.us/technical-analysis/CBBT
GREAT!!! I'll snap up ANOTHER SEVERAL MILLION SHARES! Right now I only need to hit 0.05 to rake in $ a Half-Million Bucks!$ LOL! At .10 cents I'll rake in over $1 Milion! LOL!
Sounds like you need to transition over to NASDAQ or NYSE where Biotech's trade at $50-$250/share and higher! Lots of built-in "good news." You would probably be a lot more comfortable.
Hope you're right!
Hope you're right!
When do you anticipate the "62 Week Low" to occur??
EXCELLENT POST! Thank you for your amazing DD!
By any chance do you know what CBBT's Float is?? iHub says 4M, but other financial websites like Yahoo says 139M.
Thanks!
What's that you stated?? "are you sure you contacted CBBT's Investors Relations Service?" Yeah, I'M REAL SURE!!! Why don't you email them and ask them the same question??????
I simply misapplied the term "Merger" in my post here, B.F.D. I meant to say "Acquisition" as this is what I asked Investor Relations TODAY 10/27/20 via email:
Here's the exact copy of my email to CBBT's Investor Relations and what the reply was:
REPLY:
12:47 PM - 10/27/20
Subject Box: RE: PKG Acquisition
Good Day Sir,
Thank you for your interest in Cerebain Biotech Corporation.
Attached is a .jpg file of our letter to PKG customers. In that letter we have targeted mid-November as the closing date of the PKG acquisition. Nothing as of this time should delay this process.
If you need further information, our FACEBOOK and TWITTER profiles contain all of the company’s public announcements. Keep following them for further updates.
Regards,
Alan Klitenic
Cerebain Biotech Investor Relations
ir@cerebain.com
P.S. I don't like "Nonsense" OR "BS" anymore than you do.
Thanks for bringing that to my attention. My misuse of terms. Yes, you are 100% CORRECT! An Acquisition is an outright purchase take over of another company on a "cash-stock" buy out! Other words, CBBT will outright own PKG. That's far better than a Merger!
Bottom line: improved company performance and shareholder value over the long-term!
Thanks for your feedback! 100X BETTER!
Classic stair-step to the stars....and they've got the rocket power with the Merger for it to rise to mind blowing heights!
A perfect storm setting up for that to happen as follows:
1). Merger (should be complete by quote: "mid-November" according to email response sent to me today by CCBT Investor Relations based on me asking for this information!
2). Extremely small Float, i.e. 59.0 Million, totally unheard of for a Biotech Company.
3). Post Merger, combined with streamline in-house capacity for product development and commercialization, translates into faster sales delivery to end users on a global level with serious cash flow earnings hitting their bottom line! This will surely attract Institutional Investors and Hedge Funds and also a higher percentage of Insider Ownership more than it already is! i.e. like maybe going from 1.4% (as of today) to 30% or higher! The lower the available float for trading, the higher the PPS rises!
4). Institutional-Hedge Fund Investors as a result of #3 that will undoubtedly begin snapping up a large percentage of the 4M Float when all the above comes onto their radar! This by itself could send the PPS North of $100/share from single dollar digit levels in a single trading session! I've seen it happen!
PPS after a solid year of all the above this time next year? My estimate: $20-$50 per share, easily!
Biotech's have a well established history of trading at 40-80X earnings, and some with ZERO EARNINGS are known to trade above $8. Take CytoDyn for example, a Penny Stock with a 52 week trading history of $0.52-to-$10,(12/3/19 -6/30/20), presently trading at $2.50, and today they still have NO EARNINGS! Have a look for yourself.
Near term PPS IMO: $1 rising to $5 between December 2020 to end of 1st Quarter 2021.
All aboard! Last call for penny level buy in!
Please keep in mind everyone that Amazon & Apple were once Penny Stocks!
News from CBBT - 10/27/20
I contacted CBBT's Investor Relations today by email to inquire about the Merger target date with PKG, and here's what the response was word-for-word:
"We anticipate mid-November as the closing date of the PKG acquisition. Nothing as of this time should delay this process."
Thank you for your inquiry.
Alan Klitenic
Cerebain Biotech Investor Relations
ir@cerebain.com
I totally agree!
Once the merger is complete, the added value alone of the acquisition should push the PPS North of $1.00 or higher within a few days.
The $1 to $2 range short term IMO is a given.
Within one year, I would expect to see it trading above $5 and as high as $8, so this is definitely a stock to accumulate and hold.
The current PPS is irrelevant.
AMEN!!!
Just initiated a position yesterday! This stock has had a series of incredible break-outs over the past 12 months to astonishing % Gains in the 1,000% to 3,000 % range! Also, if I remember correctly, it was once trading above $1. You can find its trading history on BarChart. Take a look!
It in fact has hit multiple "new highs" over the past 12 Months:
Past 5-Days 3 times
Past 1-Month 14 times
Past 3-Months 26 times
6-Months 29 times
YTD 12 times
Well, at least early morning trading Buy vs Sell Volume is: 16.2M to 13.5M respectively. BUY Volume right now is 3 Million higher than Sell, and the PPS is rising.
Stay tuned ......
So much for "0.10 by Friday as one Poster put it." Not a Flipper so the pps didn't stop me for snapping up over 100K Shares on the quick just for starters! If it goes sub-penny, all the better! Great opportunity to snap up Shares in Million increments! Nothing to fear but everything to gain!
Any predictions for opening PPS tomorrow, Monday 10/26?
It's interesting to note that ENZC went UP on Friday 10/23/20 despite the fact Trading Volume was 24.7M BUY Vs 26.3M SELL.
Be well and prosper...
Dude...what's your problem??? Would you please STOP all your Stock Symbol Spamming.
Dude...what's your problem??? Would you please STOP all your Stock Symbol Spamming.
Dude...what's your problem??? Would you please STOP all your Stock Symbol Spamming.
Definitely MOVING UP from here onward with Great News out today 10/22/20
ALL LIGHTS GREEN ACROSS THE BOARD!!!
The Company has also procured a commitment for funding of $500,000.00 to be used for implementation of the planned combined operations and the initial steps of the merged business strategy of creating successful therapeutics against infectious diseases thereby increasing the value of the Company's technology and the value of the Company through the combination the Enzolytics ITV-1 peptide in conjunction with BioClonetics' anti-HIV monoclonal antibodies. As part of this initial $500,000.00 funding, the Company and certain of its current convertible debt holders have agreed to a standstill on the issuance of any additional shares from conversions of debt.
The entities anticipate a decision in the near future on pending applications filed with the National Institute of Health (NIH) and the National Science Foundation (NSF) for further development of its anti-HIV monoclonal antibodies and proposed production of anti-SARS-CoV-2 (CoronaVirus) antibodies.
Enzolytics' application with OTC Markets was approved and ENZC has begun the process of bringing its filings current having filed the September 30, 2018 report.
In addition, management of ENZC is scheduling a meeting with a GMP manufacturer anticipated to take place before the end of the month.
"We are moving forward on the combination of our two companies, including the intellectual property owned by each, and are finalizing the necessary documents to bring the transaction to a successful closure in the very near future" said Charles Cotropia CEO of ENZC.
Harry Zhabilov CSO stated, "It has long been a dream of mine to be able to partner with an individual and management team such as BioClonetics to realize the full value of the Company's patented technology for ENZC and its shareholders."
Enzolytics-BioClonetics recent Press Releases finding its way into local News publications around the Country!
1). Illinois Intelligencer
https://www.illinoisintelligencer.com/news/266687444/enzolytics-inc-announces-execution-of-binding-letter-of-intent-for-merger-with-bioclonetics-immunotherapeutics-inc
2). Miami Mirror
https://www.miamimirror.com/news/266732556/enzolytics-inc-shares-bioclonetics-immunotherapeutics-inc-company-update
Be well and prosper...
Well said! It is indeed a "Reverse Merger" transaction, which is also commonly referred to as an Acquisition!
Here's the definition of what we are about to see happen between Enzolytics and BioClonetics....
What is a Reverse Merger?
Definition:
A Reverse Merger is when a Private Company (BioClonetics) goes public by acquiring an already-public Company (Enzolytics).
This is referred to as a "Reverse Merger" because it's less common for a private company to acquire a public company." Generally it's the opposite!
Simply put, BioClonetics is acquiring Enzolytics!
It is also possible post-reverse merger, that the new entity will be accompanied by a name change, as is the case also for any merger, OR the new company Board made up of the principals of both companies could decide to maintain the name of the already public company (Ezolytics).
Overall, the merger adds significant increase value to the underlying stock of the public company (Enzolytics) due to the existing substantial valuation of the acquiring company aka: "parent company" (BioClonetics).
IMO, I fully anticipate that upon post-merger, Enzolytic's stock price will increase significantly and gradually rise thereafter as more developments occur all the way to pharmaceutical commercialization of its Clone-3 Patent.
Be well and prosper ...
If you bought into this "stock" you've been had!
https://www.johnschapman.com/investment-fraud/five-individuals-charged-in-penny-stock-pump-and-dump-scheme/
Something to think about...
https://www.youtube.com/embed/YMy0_LdO2aE
Be well and prosper . . .